Skip to Main Content

Paper Details

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
JACC Heart Fail
57
2021
ATTR, ATTR-CM, ATTRv, ATTRv-, ATTRwt, Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy, Patients, Tafamidis, Transthyretin, Transthyretin Cardiomyopathy, cardiomyopathy, patients, tafamidis, transthyretin, transthyretin amyloid cardiomyopathy, wild-type transthyretin
Author NameAffiliation
Eric J VelazquezYale School of Medicine
Eric J VelazquezYale School of Medicine
Kurt BomanResearch Unit, Skelleftea County Hospital, Department of Public Health and Clinical Medicine, Umea University
  • 1 - 3

Datasets

Release 1.2